Alaris PC unit model 8015 with software version 9.12 Product Usage: The Alaris PC unit is t...

FDA Device Recall #Z-1112-2013 — Class II — March 6, 2013

Recall Summary

Recall Number Z-1112-2013
Classification Class II — Moderate risk
Date Initiated March 6, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Carefusion Corporation
Location San Diego, CA
Product Type Devices
Quantity 4,090 total units

Product Description

Alaris PC unit model 8015 with software version 9.12 Product Usage: The Alaris PC unit is the central programming, monitoring and power supply component for the Alaris System

Reason for Recall

The recall was initiated because Carefusion has identified potential risk associated with bolus programming with the Alaris PC unit (model 8015) software version 9.12. Automating infusion pump parameter input from either the electronic medical record (EMR) or the Alaris Auto-ID module for a continuous infusion with a bolus dose option may result in a loss of information from the Guardrails Data s

Distribution Pattern

Worldwide Distribution USA Nationwide and the countries of Australia and Canada.

Lot / Code Information

not available

Other Recalls from Carefusion Corporation

Recall # Classification Product Date
Z-1098-2013 Class I Alaris PC unit model 8015 with software version... Mar 6, 2013
Z-1015-2013 Class II Pyxis Anesthesia System Model 2000 (PAS 2000) ... Nov 20, 2009

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.